Sign Up Today and Learn More About Triomics Stock
Invest in or calculate the value of your shares in Triomics or other pre-IPO companies through EquityZen's platform.
Triomics Stock (TRIO)
Unlocking the value of clinical data for clinical research.
About Triomics Stock
Founded
2020
Headquarters
San Francisco, CA, US
Industries
Artificial Intelligence, Software, Data and Analytics
Triomics Press Mentions
Stay in the know about the latest news on Triomics
Triomics raises $22M Series B to bring Oncology-Focused AI to Cancer Centers
founderstoday • Jun 02, 2026
Trusted by Leading Cancer Centers to Solve Oncology's Information Overload, Triomics Raises $22 million to Accelerate Adoption
vcaonline • May 30, 2026
Triomics Inks $22M Series B Funding
vcnewsdaily • May 29, 2026
Triomics, which is building an AI-powered platform to help oncologists automate data-heavy tasks, raised a $22M Series B, following a $15M Series A in 2024 (Marina Temkin/TechCrunch)
techmeme • May 29, 2026
Company accidentally spent $500 million on Claude AI in one month after forgetting usage limits
techstartups • May 29, 2026
Triomics Management
Leadership team at Triomics
Co-Founder
Sarim Khan
Co-Founder
Sajjan Rajpurohit
Join now and verify your accreditation status to gain access to:
- Triomics Current Valuation
- Triomics Stock Price
- Triomics Management
- Available deals in Triomics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Triomics Cap Table and Funding History by Share Class and Liquidity Preferences
- Triomics Revenue and Financials
- Triomics Highlights
- Triomics Business Model
- Triomics Risk Factors
- Triomics Research Report from SACRA Research
Trading Triomics Stock
How to invest in Triomics stock?
Accredited investors can buy pre-IPO stock in companies like Triomics through EquityZen funds. These investments are made available by existing Triomics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Triomics stock?
Shareholders can sell their Triomics stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
